Digital Inhaler Monitoring Trial: Aflo™ Platform Shows Promise for Uncontrolled Asthma Management — Single-Arm Study Results Pending

References

1. 1.Australian Institute of Health and Welfare. (2023). Asthma in Australia 2023. AIHW. https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma-in-australia-2023
2. 2.Boston Children's Hospital. (2024). Automated Inhaler Monitoring for Asthma Medication Usage. ClinicalTrials.gov. NCT06825871. https://clinicaltrials.gov/study/NCT06825871
3. 3.Chan, A. H., Stewart, A. W., Harrison, J., Camargo Jr, C. A., Black, P. N., & Mitchell, E. A. (2015). The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma. American Journal of Respiratory and Critical Care Medicine, 191(5), 501-507. https://doi.org/10.1164/rccm.201410-1911OC
4. 4.Chrystyn, H., van der Palen, J., Sharma, R., Barnes, N., Delafont, B., Mahajan, A., & Thomas, M. (2017). Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Primary Care Respiratory Medicine, 27(1), 57. https://doi.org/10.1038/s41533-017-0056-y
5. 5.Levy, M. L., Hardwell, A., McKnight, E., & Holmes, J. (2013). Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy. Primary Care Respiratory Journal, 22(4), 406-411. https://doi.org/10.4104/pcrj.2013.00084